Cancer communications
Cancer Communications is the open-access English-language journal of the Chinese Anti-Cancer Association, covering basic, translational and clinical cancer research. Read by oncologists and cancer researchers, particularly those following work from China.
Overview
Cancer Communications is the official journal of the Chinese Anti-Cancer Association and the US Chinese Anti-Cancer Association. It continued the Chinese Journal of Cancer under its present title in 2018 and is an open-access, peer-reviewed online journal spanning basic, clinical and translational cancer research, including clinical trials, epidemiology, molecular and cellular biology and genetics. Recent articles are registered with Crossref under the American Association for the Advancement of Science as a Science Partner Journal (DOI prefix 10.34133), after an earlier period with Wiley, which is the publisher named on the DOAJ record. DOAJ lists CC BY and CC BY-NC-ND licences, an article processing charge with waivers, and anonymous peer review. Indexed in MEDLINE and deposited in PubMed Central.